Given that several randomised controlled trials (see {1-3}) have failed to find a beneficial effect of cyclophosphamide in the management of pemphigus, clinicians should be aware of the potential cardiac adverse effects of pulsed cyclophosphamide identified in this early study and {4}. This Recommendation is of an article referenced in an F1000Prime Report also written by Benjamin S. Daniel...